Feeling full
involves more than just the uncomfortable sensation that your waistband is
getting tight. Investigators reporting online on July 5th in the Cell Press
journal Cell have now mapped out the signals that travel between your gut and
your brain to generate the feeling of satiety after eating a protein-rich meal.
Understanding this back and forth loop between the brain and gut may pave the
way for future approaches in the treatment and/or prevention of obesity.
Credit: Duraffourd et al., Cell
Feeling full
involves more than just the uncomfortable sensation that your waistband is
getting tight. Investigators reporting online on July 5th in the Cell Press
journal Cell have now mapped out the signals that travel between your gut and
your brain to generate the feeling of satiety after eating a protein-rich meal.
Understanding this back and forth loop between the brain and gut may pave the
way for future approaches in the treatment and/or prevention of obesity.
Food intake can be modulated through mu-opioid receptors (MORs,
which also bind morphine) on nerves found in the walls of the portal vein, the
major blood vessel that drains blood from the gut. Specifically, stimulating
the receptors enhances food intake, while blocking them suppresses intake.
Investigators have now found that peptides, the products of digested dietary
proteins, block MORs, curbing appetite. The peptides send signals to the brain
that are then transmitted back to the gut to stimulate the intestine to release
glucose, suppressing the desire to eat.
Mice that were genetically engineered to lack MORs did
not carry out this release of glucose, nor did they show signs of 'feeling
full', after eating high-protein foods. Giving them MOR stimulators or
inhibitors did not affect their food intake, unlike normal mice.
Because MORs are also present in the neurons lining the
walls of the portal
vein in humans, the mechanisms uncovered here may also take place in
people.
"These findings explain the satiety effect of dietary protein,
which is a long-known but unexplained phenomenon," says senior author Dr.
Gilles Mithieux of the Université de Lyon, in France. "They provide a
novel understanding of the control of food intake and of
hunger sensations, which may offer novel approaches to treat obesity in the
future," he adds.
More information: Duraffourd et
al.: "Mu-Opioid Receptors and Dietary Protein Stimulate a Gut-Brain Neural
Circuitry Limiting Food Intake." Cell,
DOI:10.1016/j.cell.2012.05.039
Abstract
Intestinal gluconeogenesis is involved in the control of food intake. We show that mu-opioid receptors (MORs) present in nerves in the portal vein walls respond to peptides to regulate a gut-brain neural circuit that controls intestinal gluconeogenesis and satiety. In vitro, peptides and protein digests behave as MOR antagonists in competition experiments. In vivo, they stimulate MOR-dependent induction of intestinal gluconeogenesis via activation of brain areas receiving inputs from gastrointestinal ascending nerves. MOR-knockout mice do not carry out intestinal gluconeogenesis in response to peptides and are insensitive to the satiety effect induced by protein-enriched diets. Portal infusions of MOR modulators have no effect on food intake in mice deficient for intestinal gluconeogenesis. Thus, the regulation of portal MORs by peptides triggering signals to and from the brain to induce intestinal gluconeogenesis are links in the satiety phenomenon associated with alimentary protein assimilation.
Intestinal gluconeogenesis is involved in the control of food intake. We show that mu-opioid receptors (MORs) present in nerves in the portal vein walls respond to peptides to regulate a gut-brain neural circuit that controls intestinal gluconeogenesis and satiety. In vitro, peptides and protein digests behave as MOR antagonists in competition experiments. In vivo, they stimulate MOR-dependent induction of intestinal gluconeogenesis via activation of brain areas receiving inputs from gastrointestinal ascending nerves. MOR-knockout mice do not carry out intestinal gluconeogenesis in response to peptides and are insensitive to the satiety effect induced by protein-enriched diets. Portal infusions of MOR modulators have no effect on food intake in mice deficient for intestinal gluconeogenesis. Thus, the regulation of portal MORs by peptides triggering signals to and from the brain to induce intestinal gluconeogenesis are links in the satiety phenomenon associated with alimentary protein assimilation.
Provided by Cell Press
No comments:
Post a Comment